Twelve years of progressive Mycobacterium abscessus lung disease in CF-Response to Trikafta

Pediatr Pulmonol. 2021 Dec;56(12):4048-4050. doi: 10.1002/ppul.25637. Epub 2021 Aug 25.

Authors

Michal Gur^{1

2}, Ronen Bar-Yoseph^{1

2}, Yazeed Toukan^{1

2}, Moneera Hanna¹, Kamal Masarweh¹, Lea Bentur^{1

2}

Affiliations

¹ Pediatric Pulmonary Institute and CF Center, Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel.
² Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

PMID: 34432957
DOI: 10.1002/ppul.25637

No abstract available

Keywords: Trikafta; cystic fibrosis; mutation-specific; nontuberculous mycobacteria.

Publication types

Letter

MeSH terms

Aminophenols
Benzodioxoles
Drug Combinations
Humans
Indoles
Lung Diseases* / etiology
Mycobacterium Infections, Nontuberculous* / diagnosis
Mycobacterium abscessus*
Nontuberculous Mycobacteria
Pyrazoles
Pyridines
Quinolines

Substances

Aminophenols
Benzodioxoles
Drug Combinations
Indoles
Pyrazoles
Pyridines
Quinolines
elexacaftor, ivacaftor, tezacaftor drug combination